Inflammatory Bowel Disease III: Crohn's Disease
Genome-wide Association Studies-GWAS
Human Genetics
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Chronic Inflammation: Introduction
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 23, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Casper G Noomen1, Daniel W Hommes, Herma H Fidder
1Department of Gastroenterology and Hepatology, Leiden University Medical Center, C4-12 Leiden, the Netherlands. c.g.noomen@lumc.nl
Inflammatory bowel disease (IBD) involves immune system dysfunction and gut factors. Recent genetic studies, including genome-wide association studies (GWAS), reveal over 30 new gene regions linked to IBD pathogenesis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: